Tejnaksh Healthcare Ltd - 539428 - Closure of Trading Window
Please find the letter attached for the quarter and year ended 31st March 202426-03-2024
26-03-2024
Tejnaksh Healthcare Ltd - 539428 - Submission Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended On 31St December 2023.
Please Find Attached Result12-02-2024
Tejnaksh Healthcare Ltd - 539428 - Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
In continuation of our Letter dated 5th February, 2024 we wish to inform you that a meeting of the Board of Directors of the Company was held on Monday, 12th February, 2024 at A 601, Floor No.6, Kailash Business Park, Veer Savarkar Marg, Vikroli - West, Mumbai - 400079 at 5.30 p.m. and has transacted the following: - 1. Considered and approved Un-Audited Financial Results (Standalone & Consolidated) for the quarter ended on 31st December 2023 and took note of Limited Review Report thereon, in terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; The meeting of Board of Directors commenced at 5.30 p.m. and concluded at 9.30 pm12-02-2024
Tejnaksh Healthcare Ltd - 539428 - Board Meeting Intimation for Regulation 29 Of SEBI (LODR) Regulations, 2015 And Closure Of Trading Window
Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, We hereby inform you that a meeting of the Board of Directors of the Company will be held on Monday, 12TH February, 2024 at A 601, Floor No.6, Kailash Business Park, Veer Savarkar Marg, Vikroli - West, Mumbai - 400079 to transact the business as given below: 1. To Consider and approve Un-Audited Financial Results (Gtandalone & Consolidated) for the Quarter Ended on 31st December 2023. 2. Any other matter with the permission of the Chair.05-02-2024
Tejnaksh Healthcare Ltd - 539428 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please Find Certificate Attached19-01-2024
Tejnaksh Healthcare Ltd - 539428 - Announcement Under Regulation 30 --Incredible Achievement In Urology Innovation
Please Find Attached for incredible achievement in Urology Innovation in detail.01-01-2024
Tejnaksh Healthcare Ltd - 539428 - Closure of Trading Window
Please find Attached Detail for Closure of Trading Window30-12-2023
Tejnaksh Healthcare Ltd - 539428 - Announcement Under Regulation 30 - 7Th Innovation Patent Granted
Dr Ashish Rawandale Managing Director of Company have granted Patent for Percutaneous Access Device.. Please find attached letter for more detail01-12-2023
Tejnaksh Healthcare Ltd - 539428 - Submission Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended On 30Th September, 2023.
Please find enclosed financial statement (Consolidated and Standalone) for the quarter and half year ended 30th September 202311-11-2023
Tejnaksh Healthcare Ltd - 539428 - Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
In continuation of our Letter dated 2nd November, 2023 we wish to inform you that a meeting of the Board of Directors of the Company was held on Saturday, 11th November, 2023 at A 601, Floor No.6, Kailash Business Park, Veer Savarkar Marg, Vikroli - West, Mumbai - 400079 at 4.00 p.m. and has transacted the following:- 1. Considered and approved Un-Audited Financial Results (Standalone & Consolidated) for the quarter ended on 30th September 2023 and took note of Limited Review Report thereon, in terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; The meeting of Board of Directors commenced at 4.00 p.m. and concluded at 5.00 pm11-11-2023